Skip to content

Comparison of Two Non- Diffractive Extended Depth of Focus Intraocular Lenses

Intraindividual Comparison of Two Non- Diffractive Extended Depth of Focus Intraocular Lenses Set for Emmetropia

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06607848
Enrollment
40
Registered
2024-09-23
Start date
2024-07-29
Completion date
2026-07-01
Last updated
2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Keywords

EDOF IOL, presbyopia-correction, Cataract

Brief summary

Intra-individual comparison of the PureSee EDOF IOL with the Acunex Vario EDOF IOL set for emmetropia.

Detailed description

Spectacle-independence is a growing goal in modern cataract surgery. The procedure has evolved from a simple restoration of vision to a presbyopia correction approach. Although bilateral monofocal IOL implantation with the goal of emmetropia results in high patient satisfaction for distance vision, spectacle-dependence for reading and intermediate vision tasks is the usual outcome. Enhanced Depth of Focus (EDOF) lenses have been on the market for some time to minimize this spectacle-dependency in intermediate tasks (computer work, dashboard, etc.). These IOLs have an extended distance focal range that extends into the intermediate distance, providing high quality vision over a continuous focal range, rather than single foci with blurring in between. The risk to the patient is comparable to that of all other monofocal systems, which generally have high patient satisfaction. The benefit of this study should be continuous sharp binocular vision at distance, intermediate (66 cm) and even near (40 cm). Another expected effect is the reduction of dysphotopic phenomena compared to other EDOF lenses. The aim of this study is to compare the visual performance of two refractive EDOF lenses, namely the Acunex Vario with the Puresee IOL, in an intraindividual comparative study design. In order to achieve a satisfactory result, we planned to include 40 patients scheduled for cataract surgery in the study. The examinations will all take place one week before, 1 week and 4-6 months after the operation. These include a visual acuity check at the three distances mentioned, slit lamp examination, pressure control, biometry, pupil width, defocus curve, quality of vision questionnaires, contrast sensitivity, halo&glare, optical coherence tomography, fundus examination, aberrometry and keratometry. The main parameter to be examined is the distance-corrected visual acuity for the intermediate distance (66 cm) between the two IOLs at the follow-up examination after 4-6 months.

Interventions

DEVICELow-Add EDOF IOL

Acunex Vario AN6V

DEVICEEDOF IOL

PureSee EDOF IOL

Sponsors

Vienna Institute for Research in Ocular Surgery
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to 105 Years
Healthy volunteers
No

Inclusion criteria

* Age-related bilateral cataract * Age 21 or older * Visual acuity > 0.05 * For patients with regular corneal astigmatism greater than or equal to 1.00 dpt toric IOLs will be implanted * Normal findings in the medical history and physical examination unless the investigator considers an abnormality to be clinically relevant * Written informed consent prior to surgery

Exclusion criteria

* Active ocular disease (e.g chronic uveitis, diabetic retinopathy, chronic glaucoma not responsive to medication, corneal dystrophies, etc.) precluding good post-operative visual acuity * Relevant other ophthalmic diseases such as pseudoexfoliation syndrome (PEX) * Corneal decompensation or corneal endothelial cell insufficiency * Irregular astigmatism on corneal tomography * Pronounced dry eye disease * Previous ocular surgery or trauma * Persons who are pregnant or nursing (pregnancy test will be taken in women of reproductive age)

Design outcomes

Primary

MeasureTime frameDescription
Distance corrected visual acuity for intermediate distance6 monthsDistance corrected visual acuity for intermediate distance given in logMAR will be measured at 66 cm using ETDRS charts

Secondary

MeasureTime frameDescription
Uncorrected and distance corrected visual acuity for far distance6 monthsUncorrected and distance corrected visual acuity for far distance given in logMAR will be measured at 4 m using ETDRS charts
Uncorrected and distance corrected visual acuity for near distance6 monthsUncorrected and distance corrected visual acuity for near distance given in logMAR will be measured at 40 cm using ETDRS charts
Defocus curve assessment6 monthsMonocular defocus curves will be assessed in logMAR at 4 m using an ETDRS chart
Uncorrected visual acuity for intermediate distance6 monthsUncorrected visual acuity for intermediate distance given in logMAR will be measured at 66 cm using ETDRS charts
Contrast sensitivity6 monthsContrast sensitivity will be tested using the Optec device
Subjective rating of dysphotopsia6 monthsDysphotopsia will be subjectively rated by the patients using a questionnaire and a visual analogue scale
Halometry6 monthsPotential halos will be assessed using the Aston Halometer App provided on a Tablet at 2 m

Countries

Austria

Contacts

Primary ContactJohannes Zeilinger, MD
office@viros.at01 91021 57564
Backup ContactManuel Ruiss, MSc
office@viros.at01 91021 57564

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026